Advertisement

A useful combination for the treatment of patellofemoral chondral lesions: realignment procedure plus mesenchymal stem cell—retrospective analysis and clinical results at 48 months of follow-up

  • Roberto Buda
  • Matteo BaldassarriEmail author
  • Luca Perazzo
  • Diego Ghinelli
  • Gherardo Pagliazzi
Original Article • KNEE - BIOMATERIALS
  • 38 Downloads

Abstract

Introduction

Osteochondral lesions of the patellofemoral joint (OLPFJ) are defects of the cartilage surface and subchondral bone, which often require surgical treatment. Reparative treatments have shown some limitations in the long-term follow-up. The one-step bone marrow-derived cells transplantation (BMDCT) achieved good to excellent results in the treatment of osteochondral lesions of the femoral condyles. The aim of this study was to report the 48-month clinical and radiological results among 28 patients with OLPFJ treated with the one-step BMDCT technique associated with the anteromedialization tibial tuberosity (AMTT).

Materials and methods

Twenty-eight patients from 2010 to 2013 with OLPFJ underwent the BMDCT with the one-step technique associated with the AMTT. Clinical evaluation was performed at 6, 12, 18, 24, 36 and 48 months after surgery using the Kujala PF scale, the IKDC score and the Tegner activity scale. Eighteen lesions were located on patella and ten lesions on trochlea.

Results

The preoperative Kujala score improved from 68.2 ± 4.7 to 87.2 ± 1.2 at the mean final follow-up, while the IKDC subjective score improved from 55.1 ± 6.2 to 92.13 ± 5.5. Tegner scale showed an increase from 1.7 ± 1.3 preoperatively to 5.3 ± 2.7 at the final follow-up. MRI analysis at 24-month follow-up showed an overall good filling of the lesions.

Discussion and conclusions

The one-step BMDCT associated with the AMTT permitted good clinical results durable over time with a high rate of patients’ satisfaction. These results confirm the validity of the one-step technique also in patellofemoral joint.

Keywords

Patello-femoral Knee Ostechondral lesion Stem cells 

Notes

Compliance with ethical standards

Conflict of interest

All the authors declare no conflict of interest.

References

  1. 1.
    Anderson DM, Michelle AE (2004) Mosby’s medical, nursing, and allied health dictionary, vol 6. Piccin, VeniceGoogle Scholar
  2. 2.
    Curl WW, Krome J, Gordon ES, Rushing J, Smith BP, Poehling GG (1997) Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy 13:456–460CrossRefGoogle Scholar
  3. 3.
    Hunziker EB (2002) Articular cartilage repair: basic science and clinical progress: a review of the current status and prospects. Osteoarthr Cartil 10:432–463CrossRefGoogle Scholar
  4. 4.
    Nomura E, Inoue M, Kurimura M (2003) Chondral and osteochondral injuries associated with acute patellar dislocation. Arthroscopy 19:717–721CrossRefGoogle Scholar
  5. 5.
    Messner K, Maletius W (1996) The long-term prognosis for severe damage to weight-bearing cartilage in the knee: a 14-year clinical and radiographic follow-up in 28 young athletes. Acta Orthop Scand 67:165–168CrossRefGoogle Scholar
  6. 6.
    Hangody L, Kish G, Karpati Z, Szerb I, Udvarhelyi I (1997) Arthroscopic autogenous osteochondral mosaicplasty for the treatment of femoral condylar articular defects: a preliminary report. Knee Surg Sports Traumatol Arthrosc 5:262–267CrossRefGoogle Scholar
  7. 7.
    Peterson L, Minas T, Brittberg M et al (2000) Two- to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop 374:212–234CrossRefGoogle Scholar
  8. 8.
    Gobbi A, Kon E, Berruto M, Filardo G, Delcogliano M, Boldrini L, Bathan L, Marcacci M (2009) Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation: results at 5 years’ follow-up. Am J Sports Med 37(6):1083–1089CrossRefGoogle Scholar
  9. 9.
    Macmull S, Jaiswal PK, Bentley G, Skinner JA, Carrington RWJ, Briggs TW (2012) The role of autologous chondrocyte implantation in the treatment of symptomatic chondromalacia patellae. Int Orthop 36(7):1371CrossRefGoogle Scholar
  10. 10.
    Cavallo C, Desando G, Cattini L, Cavallo M, Buda R, Giannini S, Facchini A, Grigolo B (2013) Bone marrow concentrated cell transplantation: rationale for its use in the treatment of human osteochondral lesions. J Biol Regul Homeost Agents 27(1):165–175Google Scholar
  11. 11.
    Giannini S, Battaglia M, Buda R, Cavallo M, Ruffilli A, Vannini F (2009) Surgical treatment of osteochondral lesions of the talus by open-field autologous chondrocyte implantation: a 10-year follow-up clinical and magnetic resonance imaging T2-mapping evaluation. Am J Sports Med 37(Suppl 1):112S–118SCrossRefGoogle Scholar
  12. 12.
    Giannini S, Buda R, Faldini C et al (2005) Surgical treatment of osteochondral lesions of the talus (OLT) in young and active patients: guidelines for treatment and evolution of the technique. J Bone Joint Surg Am 87:28–41Google Scholar
  13. 13.
    Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331(14):889–895CrossRefGoogle Scholar
  14. 14.
    Mandelbaum B, Browne JE, Fu F, Micheli LJ, Moseley JB, Erggelet C, Anderson AF (2007) Treatment outcomes of autologous chondrocyte implantation for full-thickness articular cartilage defects of the trochlea. Am J Sports Med 35(6):915–921CrossRefGoogle Scholar
  15. 15.
    Minas T, Bryant T (2005) The role of autologous chondrocyte implantation in the patellofemoral joint. Clin Orthop Relat Res 436:30–39CrossRefGoogle Scholar
  16. 16.
    Peterson L, Brittberg M, Kiviranta I, Akerlund EL, Lindahl A (2002) Autologous chondrocyte transplantation: biomechanics and long-term durability. Am J Sports Med 30(1):2–12CrossRefGoogle Scholar
  17. 17.
    Trinh T, Harris J, Siston R, Flanigan D (2013) Improved outcomes with combined autologous chondrocyte implantation and patellofemoral osteotomy versus isolated autologous chondrocyte implantation. Arthroscopy 29(3):566–574CrossRefGoogle Scholar
  18. 18.
    Salter RB (1994) The physiological basis of continous passive motion for articular cartilage healing and regeneration. Hand Clin 10:211–219Google Scholar
  19. 19.
    Ding DY, Kanevsky R, Strauss EJ, Jazrawi LM (2016) Anteromedialisation tibial tubercle osteotomy for recurrent patellar instability in young active patients: a retrospective case series. Injury 47(3):7373–41CrossRefGoogle Scholar
  20. 20.
    Kreuz PC, Steinwachs MR, Erggelet C et al (2006) Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthr Cartil 14:1119–1125CrossRefGoogle Scholar
  21. 21.
    Saris DB, Vanlauwe J, Victor J et al (2008) Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 36:235–246CrossRefGoogle Scholar
  22. 22.
    Lorentzon R, Alfredson H, Hildingsson C (1998) Treatment of deep cartilage defects of the patella with periosteal transplantation. Knee Surg Sports Traumatol Arthrosc 6:201CrossRefGoogle Scholar
  23. 23.
    Schonholtz GJ, Ling B (1985) Arthroscopic chondroplasty of the patella. Arthroscopy 1:92–96CrossRefGoogle Scholar
  24. 24.
    Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L (1994) Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331:889–895CrossRefGoogle Scholar
  25. 25.
    Farr J II (2008) Autologous chondrocyte implantation and anteromedialization in the treatment of patellofemoral chondrosis. Orthop Clin N Am 39:329–335CrossRefGoogle Scholar
  26. 26.
    Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T (2006) Chondrogenic differentiation of bovine marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng 93:1152–1163CrossRefGoogle Scholar
  27. 27.
    Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM (2004) Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. PNAS 101:11761–11766CrossRefGoogle Scholar
  28. 28.
    Kacena MA, Gundberg CM, Horowitz MC (2006) A reciprocal regulatory interaction between megakaryocytes, bone cells and hematopoietic stem cells. Bone 39:978–984CrossRefGoogle Scholar
  29. 29.
    Longobardi L, O’Rear L, Aakula S, Johnstone B, Shimer K, Chytil A, Horton WA, Moses HL, Spagnoli A (2006) Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21:626–636CrossRefGoogle Scholar
  30. 30.
    Tsujii A, Hiramatsu K, Shimomura K, Kobayashi M, Mera H, Wakitani S, Nakamura N, Horibe S, Mitsuoka TJ (2018) Long-term results of autologous bone marrow mesenchymal stem cell transplantation for cartilage defects in the patella: Two case reports with more than 18 years of follow-up. Orthop Sci S0949–2658(18):30036–30038Google Scholar
  31. 31.
    Wakitani S, Nawata M, Tensho K, Okabe T, Machida H, Ohgushi H (2007) Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 1(1):74–79CrossRefGoogle Scholar
  32. 32.
    Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S (2004) Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transpl 13(5):595–600CrossRefGoogle Scholar

Copyright information

© Springer-Verlag France SAS, part of Springer Nature 2018

Authors and Affiliations

  1. 1.I Clinic, Rizzoli Orthopedic InstituteBologna UniversityBolognaItaly
  2. 2.Villa Maria HospitalRiminiItaly
  3. 3.Ospedale Regionale di Mendrisio “Beata Vergine”MendrisioSwitzerland

Personalised recommendations